Background/objective: Cardiovascular risk depends largely on paraoxonase (PON-1) and apolipoprotein A4 (APOA4) gene polymorphisms. To compare the effects of consumption of walnut-enriched meat versus low-fat meat (LM) on selected soluble adhesion molecules and leukotrienes (LTB4). Subjects/Methods: In all 22 subjects at increased cardiovascular risk were taken. It is a non-blinded, cross-over, placebocontrolled study. Two 5-week experimental periods separated by 4-6 week wash-out interval. Participants consumed walnutenriched meat during one period and LM during the other. Diet characteristics, HDLc, Apo A1, paraoxonase, sVCAM-1, sICAM-1 and LTB4 were analysed. PON-1 55, PON-1 192 and APOA4 360 polymorphism effects were also assessed. Results: Individuals consuming walnut-enriched meat displayed higher paraoxonase activity (Po0.001), lower levels of sICAM and aVCAM (P ¼ 0.046, P ¼ 0.012, respectively) and leukotriene B4 (P ¼ 0.044), and lower paraoxonase-1/HDLc and paraoxonase-1/Apo A1 ratios (both, Po0.001) than those consuming LM. Paraoxonase levels correlated negatively with those of sICAM (r ¼ À0.471, Po0.01). Significant decreases (at least Po0.05) were observed in sICAM concentrations in PON-1 55LM þ MM, PON-1 QQ192 and APOA4-2 carriers while decreases in sVCAM in QR þ RR and APOA4-1 carriers were observed. Paraoxonase-1/HDLc and paraoxonase-1/Apo A1 ratios were significantly influenced by paraoxonase polymorphisms. Conclusions: Walnut-enriched meat appears as a functional meat as consumed in the framework of a mix diet lowered the concentration of some selected inflammatory chemoattractant biomarkers. This effect was largely influenced by PON-1 and Apo A4-360 polymorphisms.
Introduction
Leukotriene B4 (LTB4) is as a potent proinflammatory factor acting as a chemoattractant for polymorph nuclear leukocytes and for other cells to damaged endothelium. Cytokines released by these cells stimulate expression of soluble vascular and intercellular cell adhesion molecules (sVCAM-1 and sICAM-1, respectively) (Terry et al., 1993) . Although the origin and metabolism of sVCAM-1 and sICAM-1 are not fully understood, studies that have measured serum or plasma levels of these cell adhesion molecules indicate that elevated sICAM-1 levels may be a marker for coronary heart disease (CHD) risk and atherosclerosis (Hwang et al., 1997; Peter et al., 1997; Ridker et al., 1998; Blann and Lip, 2000; Blankenberg et al., 2001) .
The paraoxonase 1 (PON-1) exerts protective cardiovascular effects (Aviram et al., 1998; Canales and Sánchez-Muniz, 2003) . However, whether PON-1 acts as an antioxidant by increasing its activity, modifying HDL composition or acting as a suicide enzyme has not yet been determined (Durrington et al., 2001; Canales and Sánchez-Muniz, 2003) . Our group found that walnut paste-enriched meat improved the antioxidant status of individuals at increased CHD risk (Canales et al., , 2009 Nus et al., 2007) . The walnut paste-enriched meat lowered platelet aggregation and thromboxane B 2 levels, and the thromboxane B 2 /prostacyclin (6-keto-PF 1a ) ratio to a greater degree than low fat meat (LM) (Canales et al., 2009) . Moreover, thrombogenic index values varied due to interaction between consumption of walnut paste-enriched meat and LM and apolipoprotein A4 (APOA4) 360 gene polymorphisms (Canales et al., 2010) , and variations in antioxidant enzyme concentrations and PON-1 gene polymorphism levels were also detected (Jiménez-Colmenero et al., 2010) . Present hypothesis is that intake of walnut paste-enriched meat may reduce inflammatory and leukocyte chemoattractant responses by modifying sVCAM-1, sICAM-1 and LTB4 concentrations, and that these effects may depend on PON-1 and APOA4 360 gene polymorphisms. Modifications of these responses may be related to changes in PON-1 activity.
This study aims to determine (a) whether consumption of walnut paste-enriched meat altered sVCAM-1, sICAM-1 and/ or LTB4 levels in individuals at increased CHD risk; (b) whether variations of PON-1 levels and PON-1/HDLc and PON-1/ApoA1 ratios, associated or not with PON-1 and APOA4 360 gene polymorphisms, could explain the concentrations and variations of sICAM, sVCAM and LTB4.
Subjects and methods

Subjects
Of the 144 candidates initially recruited through announcements in the media and in hospitals, 25 volunteers were chosen for the trial but only 22 completed the study. Eligibility criteria for the study included the followings: (a) age of men X45 years, age of women X50 years and postmenopausal; (b) body mass index (BMI) X25-o35 kg/m 2 . In addition, one or more of the following criteria also had to be met: serum total cholesterol X5.69 mmol/l; smoking habit (X10 cigarettes per day); hypertension (systolic pressure X140 mm Hg and/or diastolic pressure X90 mm Hg). Candidates with familiar hypercholesterolaemia and/or type I diabetes, and those taking any lipidlowering, anti-hypertensive or anti-inflammatory drugs or hormone therapy were excluded from the trial. Volunteers who did not frequently consume meat (X5 times/week) were not selected, although many of them displayed three or more risk factors for CHD. Twenty-two candidates were not accepted for other reasons, such as the regular use of therapeutic medication. Three volunteers who did not complete the requisite blood extractions were also excluded from the trial. Procedures followed were in accordance with the standards of the Ethics Committee of the Puerta de Hierro University Hospital (Madrid, Spain) and the Helsinki Declaration, as indicated in the guidelines of the Scientific Technologic Project AGL 2001-2398-C03. Informed consent was given by all participants before the start of the study.
Methods
Study design. Volunteers for the non-blinded, cross-over, placebo-controlled study were randomly assigned to one of the two 5-week experimental dietary periods. Participants followed their normal dietary habits during the 4-6-week wash-out interval that separated the two trial periods. During the walnut paste-enriched meat period, volunteers consumed four 150 g restructured walnut paste-enriched steaks and a 150 g ration of walnut paste-enriched sausages per week, all containing 20% walnut paste. During the LM period, volunteers consumed four 150 g restructured low-fat steaks and a 150 g ration of low-fat sausages each week. The composition of the two types of meat studied can be found in Serrano et al. (2005) . Study participants were strongly requested not to include any other meats or meat derivatives in their diet during the trials. Basal anthropometrical characteristics of the volunteers have previously been published (Canales et al., 2009) .
Dietary control and compliance. Frozen LM and walnut pasteenriched meat products were distributed to study participants on a weekly basis. Special emphasis was given to compliance and management of intake with regard to frequency, intake dates and numbers of steaks consumed. The substitution of conventional meat products by the experimental meat products in the framework of a mixed diet was confirmed and verified by regularly checking the volunteers' dietary records. Food composition tables were used to calculate the volunteers' dietary energy and nutrient intakes (Moreiras et al., 2007) . Participants recorded the amount and kinds of food eaten every day to avoid any possible doubt regarding their diets. In addition, plasma g-tocopherol concentrations were measured after each trial period to assess compliance .
Most volunteers (80%) reported enjoying this type of meat. Forty percent of the participants, however, commented unfavourably on the low palatability of LM. Some relevant data of nutrients consumed by volunteers during both periods are shown in Table 1 .
Anthropometric measurements. Trained staff measured weight, height, BMI, and systolic and diastolic blood pressures of the participants at the beginning and end of both periods.
Sample collection. Fasting blood samples were collected between 0730 and 1000 hours at the beginning of the study and at the end of each experimental period. Serum was separated at 4 1C and 1500 g for 30 min within 1 h of sampling. Serum lipids. HDLc was measured by enzymatic colorimetric method (CHOD-PAP, Boehringer Mannheim GmbH Diagnostica, Mannheim, Germany; RA-XT auto analyzer, Technicon, Tarrytown, NY, USA). Apo A1 was tested by turbidimetry (Grifols, Parets Del Valle's, Barcelona, Spain).
sICAM-1, sVCAM-1 and LTB4. Concentrations of sICAM-1 and sVCAM-1 in serum stored at 80 1C, were measured in all subjects of each group by enzyme-linked immunosorbent assay technique at baseline and at week 5 using a commercially available kit (BLK 4-201 for sICAM-1 and BLK 4-232 for sVCAM-1, Biolink, Dynatech Laboratories, Inc., Chantilly, VA, USA). LTB4 concentrations were also measured by enzyme-linked immunosorbent assay (Leukotriene B4 Enzyme Immunoassay Kit Catalogue No.900-068, Assay designs, Ann Arbor, MI, USA) from the same samples.
PON-1 activity. PON-1 (EC 3.1.8.1) activity was determined by measuring the rate of hydrolysis of paraoxon in p-nitrophenol catalysed by the enzyme at 37 1C and 405 nm (Tomas et al., 2000) . Frozen aliquots of pool sera were used as internal controls. One unit of PON-1 activity was defined as 1 mmol of p-nitrophenol formed per litre per minute.
Paraoxonase genotyping. DNA was extracted from peripheral blood cells using the Ultraclean Bloodspin kit (MoBio Laboratories, Carlsbad, CA, USA). PON-1 genotyping was carried out by a multiplex PCR assay (Motti et al., 2001) . Amplification of 111 and 144 pb fragments was performed using a standard PCR for PON-1-Q192R and PON-1-L55M, respectively. Reagents were purchased from Promega (Madison, WI, USA) and PCR was performed using a DNA thermocycler (Mastercycler-ep380, Eppendorf, Hamburg, Germany).
Apo A4 360 genotyping. DNA was extracted from peripheral blood cells using the Ultraclean Bloodspin kit (MoBio Laboratories). Amplification of 309-pb fragment was performed by PCR for APOA4 (Hixson and Powers, 1991) . The restriction enzyme PvuII was used to distinguish between APOA4 360Gln and 360His alleles. Individuals who were homozygous for the His allele were classified as APOA4-1 whereas those carrying the Gln allele were designated as APOA4-2. Reagents were purchased from Promega. PCR was performed using a DNA thermocycler (Mastercycler-ep380, Eppendorf).
Statistics. Data are presented as means ± s.d. Percentage changes from baseline PON-1 activity levels and sVCAM-1 concentrations were considered, a priori, the primary outcome variables. The present study was designed to have a power of 80% to detect a 30% relative difference between variations in PON-1 activity or sVCAM-1 concentrations due to the different meat diets in subjects carrying different PON-1-polymorphysms. A pooled SD of 25% for the change from baseline PON-1 or sVCAM-1 was assumed for this calculation. Repeated measures analysis of variance was used to compare the effect of walnut paste-enriched meat vs LM on the variables studied in each PON-1 allele or APOA4 360 carriers. A post hoc study was performed in each polymorphism by repeated measures analysis of variance. The Spearman correlations test was used to ascertain any relationship between changes in sVCAM-1, sICAM-1 and LTB4 concentrations and PON-1 activity level changes. Data were significant at Po0.05. The SPSS 15.0 (SPSS Inc., Chicago, IL, USA) statistical package was employed.
Results
Volunteers consuming walnut paste-enriched meat and LM displayed no significant differences in body weight and BMI (data not shown). Table 2 shows that in comparison with the LM diet, walnut paste-enriched meat significantly decreased sVCAM-1 (P ¼ 0.012), sICAM-1 (P ¼ 0.046) and LTB4 (P ¼ 0.044) levels but increased PON-1 activity (Po0.001). The walnut paste-enriched meat diet was unable to modify HDLc or ApoA1 (P40.05) values but increased (P ¼ 0.002) Table 3 shows the relationships found between PON-1, PON-1/HDLc, and PON-1/ApoA1 and sVCAM-1, sICAM-1 and LTB4. There was a significant negative correlation between changes in PON-1 activity and those of sICAM-1 (r ¼ À0.471, P ¼ 0.002). PON-1 modifications were negatively correlated with those of sICAM-1 (r ¼ À0.646; P ¼ 0.009; r ¼ À0.394; P ¼ 0.050 and r ¼ À0.582; P ¼ 0.009) for PON1 55 LL, PON1 55 LM þ MM and PON1 192 QR þ RR carriers, respectively, and (r ¼ À0.667; P ¼ 0.050) for APOA4-2 carriers, whereas PON-1 changes correlated negatively only with those of sVCAM-1 (r ¼ À0.459; P ¼ 0.0115) in APOA4-1 carriers. Significant negative correlations (at least Po0.05) between PON-1/HDLc and PON-1/ApoA1 ratios with sICAM-1 concentrations were found in PON-1 192 QR þ RR and APOA4-2 carriers. Table 4 shows the effect of walnut paste-enriched meat vs LM diets on various parameters after taking into account the interaction with PON-1 192 polymorphisms. Significant interaction between diet differences and gene alleles was found for sVCAM-1 (P ¼ 0.026). The walnut paste-enriched meat diet increased PON-1 activity (P ¼ 0.037) and the PON-1/HDLc (P ¼ 0.017) and PON-1/ApoA1 (P ¼ 0.040) ratios, and decreased that of sVCAM-1 (P ¼ 0.009) in 192 RR þ RQ carriers. In PON-1 QQ 192 carriers, the walnut pasteenriched meat diet increased PON-1 activity (P ¼ 0.001), the PON-1/HDLc (P ¼ 0.022) and PON-1/ApoA1 (P ¼ 0.004) ratios, whereas decreasing that of sICAM-1 (P ¼ 0.043). Table 5 shows the comparative effect of walnut paste-enriched meat and LM diets on the same parameters after taking into account the interaction with PON-1 55 polymorphisms. The walnut paste-enriched meat diet significantly increased PON-1 activity (P ¼ 0.002) and the PON-1/HDLc (P ¼ 0.018) and PON-1/ApoA1 (P ¼ 0.034) ratios in PON-1 55LM þ MM carriers. PON-1 55LL carriers consuming the walnut paste-enriched meat diet vs LM displayed increased PON-1 activity (P ¼ 0.009), PON-1/HDLc (P ¼ 0.012) and PON-1/ApoA1 (P ¼ 0.005) ratios but decreased sICAM (P ¼ 0.004) values. Table 6 shows the comparative effect of walnut pasteenriched meat and LM diets on the same parameters after considering the interaction with APOA4 360 polymorphisms. Walnut paste-enriched meat significantly increased PON-1 activity (P ¼ 0.001), the PON-1/HDLc (P ¼ 0.001) and PON-1/ApoA1 (P ¼ 0.001) ratios but decreased that of sVCAM-1 (P ¼ 0.05) in APOA4-1 carriers. ApoA4-2 carriers on the walnut paste-enriched meat diet displayed lower sICAM-1 (Po0.001) concentrations.
Discussion
Present study has shown for first time in bibliography that subjects at high CHD risk who consumed a walnut Values are mean ± s.d. of 22 volunteers. CI change, confidence interval for basal minus 5 week differences.
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European Journal of Clinical Nutrition paste-enriched meat diet over a 5-week period displayed significantly lower plasma levels of sVCAM-1, sICAM and LTB4 than their LM diet counterparts. Moreover, this decrease seemed to be related to changes in PON-1 activity and/or HDL composition. Several authors have suggested that the inflammatory and endothelial activation biomarkers sICAM-1 and sVCAM-1 have an important role in the atherogenic process (Hackman et al., 1996; Nakashima et al., 1998) . Hyper-expression of these soluble cell adhesion molecules occurs when the endothelium responds to inflammatory stimuli. Patients with CHD (Hwang et al., 1997) display high levels of sICAM-1 and baseline plasma levels of sICAM-1 are predictors of myocardial infarction in apparently healthy men (Ridker et al., 1998) . The sVCAM-1, meanwhile, appears to be a marker for advanced atherosclerosis, as it is mainly expressed in atherosclerotic plaques (Blake and Ridker, 2002) . HDL has been found to inhibit sVCAM and sICAM expression (Kimura et al., 2008) . The HDL-associated enzyme PON-1 may exert important antioxidant and cardiovascular protective effects (Mackness et al., 1998; Canales and Sánchez-Muniz, 2003; Nus et al., 2007) , by regulating antioxidant status , in addition to acting as a suicide enzyme (Aviram et al., 1998) . Consumption of omega-3 fatty acids increases membrane concentrations of phospholipid omega-3, decreases the production rate of LTB4 and increases that of LTB5 . Intake of walnut paste-enriched meat results in better linoleic/linolenic and omega-6/omega-3 dietary ratios than consumption of LM, partially explaining the decrease in LTB4 concentrations. The decrease in sVCAM-1 and sICAM-1 levels in participants consuming walnut paste-enriched meat suggests that this product inhibits inflammation to a greater degree than LM. This effect of walnut paste-enriched meat may be related, in part, to a more appropriate dietary omega-6/ omega-3 ratio and lower LTB4 concentrations, but also to an increase in plasma PON-1 activity. Whether walnuts or (11) 1.5±0. Walnut-enriched meat, adhesion molecules and PON-1 A Canales et al walnut paste-enriched meat are able to reduce the expression of sVCAM-1 and sICAM-1 remains uncertain. Omega-3 fatty acids may inhibit inflammation and endothelial activation by decreasing baseline production of hydrogen peroxide as a result of interaction between its double bonds and reactive oxygen species (De Caterina and Libby, 1996) . Our findings coincide with those of Rallidis et al. (2001) , which suggest that the reduction of sVCAM-1 expression in dyslipidaemic patients following a diet enriched with a-linolenic acid may be mainly due to the effect of a-linolenic acid, rather than that of linoleic acid, although the latter may also have a role. Walnuts constitute a source of vitamin E, which may also regulate sICAM-1 and sVCAM-1 expression (Koga et al., 2004) . The significant relationships found between the changes in PON-1 activity and LTB4 and those of soluble adhesion molecule levels, suggest that this enzyme has an additional role. PON-1 works as a systemic antioxidant (Kaur and Bansal, 2009; Lakshmy et al., 2010) , helps to maintain the activities and concentrations of other endogenous antioxidants (for example, superoxide dismutase, catalase, glutathione reductase and glutathione peroxidase) (unpublished data), and to decrease chemoattractants and inflammatory molecules, as has been shown in the present paper. Gene-diet interactions may be responsible for the differences found in study participants. The interaction of APOA4 360 polymorphisms on platelet aggregation and thrombogenesis in individuals consuming walnut paste-enriched meat has been reported previously (Canales et al., 2010) . The APOA4-1 allele has been associated with variations in sICAM-1 levels, whereas the APOA4-2 allele has been linked with sVCAM-1 modifications, suggesting that despite their relationship, each of these molecule is expressed or regulated independently (Hag et al., 2009; Zapolska-Downar and Naruszewicz, 2009 ). As LTB4 did not change in the same subjects, data suggest that APOA4 360 polymorphisms do not exert the same influence on cyclooxygenase as on lipoxygenase. Nonetheless, one limitation of the present study is the small number of APOA4-2 carriers tested. The net effect of PON-1 192 and PON-1 55 polymorphisms on PON-1 activity, sVCAM-1 and sICAM-1 concentrations, the ratios obtained, confirmed the relationship between PON-1 activity and adhesion molecules. The fact that walnut pasteenriched meat significantly decreases sICAM-1 levels in PON-1 192QQ and PON-1 55LM þ MM carriers may benefit apparently healthy individuals with those genotypes at risk of CHD due to high sICAM-1 concentrations (Ridker et al., 1998) . The sVCAM-1 decreased more in the less cardiovascular protected R carriers (Canales and Sánchez-Muniz, 2003) than in QQ carriers suggesting that this marker of advanced atherosclerosis expressed in atherosclerotic plaques (Blake and Ridker, 2002 ) is reduced.
Regarding BMI, no significant changes occur despite the high-energy contents of walnut paste-enriched meat. Possible explanations for this fact are the satiating effect of walnuts, the incomplete absorption of nut energy and the thermogenesis increase induced by nut polyphenols (GarciaLorda et al., 2003) . However, future studies should be addressed to test the long-term effect of walnut pasteenriched meat consumption on BMI.
In conclusion, walnut paste-enriched meat must be considered a functional food as it lowers sVCAM, sICAM and LTB4 concentrations. Its mechanism of action seems to be related to PON-1 activity and data variability depends on PON-1 and APOA4 360 gene polymorphisms. More studies are required to confirm present results.
